RARA CRAFT DATABASE for FDA Medical Devices
510(k)K260312

FDA DEVICE FACTS

Nitrile Powder Free Examination Glove, Blue Tested for Use with 32 Chemotherapy Drugs and Fentanyl Permeation Resistance Claim; Nitrile Powder Free Examination Glove, Violet Blue Tested for Use with 32 Chemotherapy Drugs, Xylazine, Fentanyl & Gastric Acid

Gmp Medicare Sdn. Bhd.

Verified FDA Record identity for medical-device development research. This overview uses only fields stated in the FDA Record and is not a Device Description.医療機器開発の調査用に、確認済みの FDA Record の識別情報を示しています。この概要は FDA Record に記載された項目だけによるもので、機器説明ではありません。

DECISION DATESeptember 8, 2026PRODUCT CODELZA

Indications for use

A patient examination glove is a disposable dev ice intended for medical purpose that is worn on the examiner's hand or finger to prevent contamination between patient and examiner.

These gloves were tested for use with Chemotherapy Drugs as per ASTM D6978-05 standard practice for assessment of medical gloves to permeation by chemotherapy drugs:

Chemotherapy Drug Permeation The following chemicals have been tested with these gloves.

#

#Concentration Drugs Detection time in MinutesConcentration (mg/ml)Breakthrough
1.Amethopterin25.0>240
2.Bleomycin Sulfate15.0>240
3.Busulfan6.0>240
4.Carboplatin10.0>240
5.Carmustine3.311.0
6.Cisplatin1.0>240
7.Cyclophosphamide20.0>240
8.Cytarabine100.0>240
9Dacarbazine10.0>240
10.Docetaxel10.0>240
11.Doxorubicin Hydrochloride2.0>240
12.Ellence2.0>240
13.Etoposide20.0>240
14.Fludarabine25.0>240
15.Fluorouracil50.0>240
16.Gemcitabine38.0>240
17.Idarubicin1.0>240
18.Ifosfamide50.0>240
19.Irinotecan20.0>240
20.Mechlorethamine1.0>240
21.Melphalan5.0>240
22.Methotrexate25.0>240
23.Mitomycin C0.5>240
24.Mitoxantrone2.0>240
25.Oxaliplatin5.0>240
26.Paclitaxel6.0>240
27.Rituximab10.0>240
28.Thiotepa10.039.0
29.Topotecan1.0>240
30.Trisenox1.0>240
31.Vincristine Sulfate1.0>240
32.Vinorelbine10.0>240
33.Fentanyl Citrate100 mcg/2mL>240

Please note that Carmustine and Thiotepa have extremely low permeation times of 11 minutes and 39 minutes respectively.

Warning: Do not use with Carmustine and Thiotepa

Fentanyl Permeation Resistance Claim- Under the testing conditions of ASTM D6978-05, Fentanyl Citrate Injection (100mcg/2ml) was found to have no breakthrough detected up to 240 minutes

A patient examination glove is a disposable device intended for medical purpose that is worn on the examiner's hand or finger to prevent contamination between patient and examiner. These gloves were tested for use with Chemotherapy Drugs as per ASTM D6978-05 standard practice for assessment of medical gloves to permeation by chemotherapy drugs: Chemotherapy Drug Permeation The following chemicals have been tested with these gloves.

#

#Concentration Drugs DetectionConcentration (mg/ml)Breakthrough time in Minutes
1.Amethopterin25.0>240
2.Bleomycin Sulfate15.0>240
3.Busulfan6.0>240
4.Carboplatin10.0>240
5.Carmustine3.310.0
6.Cisplatin1.0>240
7.Cyclophosphamide20.0>240
8.Cytarabine100.0>240
9Dacarbazine10.0>240
10.Docetaxel10.0>240
11.Doxorubicin Hydrochloride2.0>240
12.Epirubicin HCL2.0>240
13.Etoposide20.0>240
14.Fludarabine25.0>240
15.Fluorouracil50.0>240
16.Gemcitabine38.0>240
17.Idarubicin1.0>240
18.Ifosfamide50.0>240
19.Irinotecan20.0>240
20.Mechlorethamine1.0>240
21.Melphalan5.0>240
22.Methotrexate25.0>240
23.Mitomycin C0.5>240
24.Mitoxantrone2.0>240
25.Oxaliplatin5.0>240
26.Paclitaxel6.0>240
27.Rituximab10.0>240
28.Thiotepa10.030.0
29.Topotecan1.0>240
30.Trisenox1.0>240
31.Vincristine Sulfate1.0>240
32.Vinorelbine10.0>240
33.Fentanyl Citrate100 mcg/2mL>240
34.Xylazine100>240
35.Simulated Gastric AcidN/A>240

Please note that Carmustine and Thiotepa have extremely low permeation times of 10 minutes and 30 minutes respectively. Warning: Do not use with Carmustine and Thiotepa Gastric Acid Permeation Resistance Claim- Under the testing conditions of ASTM D6978-05, was found to have no breakthrough detected up to 240 minutes.

Xylazine Permeation Resistance Claim- Under the testing conditions of ASTM D6978-05, Xylazine HCl Injection (100 mg/ml) was found to have no breakthrough detected up to 240 minutes. Fentanyl Permeation Resistance Claim- Under the testing conditions of ASTM D6978-05, Fentanyl Citrate Injection (100mcg/2ml) was found to have no breakthrough detected up to 240 minutes.

Table 1: Summary of Device Performance for ASTM Standard and Biocompatibility
CharacteristicStandardsDevice Performance
DimensionASTM D6319-19 (2023)Meet
Physical PropertiesASTM D6319-19 (2023)Meet
ASTM D6319-19 (2023)Meet
ASTM D6319-19 (2023)Meet
ASTM D6124-06 (2022)Meet
ASTM D6319-19 (2023)Meet
PrimarySkinIrritation (ISO 10993-10)Passed Not a primary skin irritant under condition of the study
SkinSensitization (ISO 10993-10)Passed Not a contactsensitizer under the conditions of the study
Acute Systemic Toxicity (ISO 10993-11)Passed Underthe conditions ofthe study, therewas no evidence ofsystemic toxicity

Tables marked from the FDA document were reconstructed automatically. Check the original FDA document (links at the end of this page) for authoritative values.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: October 7, 2026